RSC-type complex GO:0016586: Components & Methods

The RSC-type complex (GO:0016586) is a multisubunit chromatin remodeling machine belonging to the SWI/SNF family of ATP-dependent remodelers. It is defined by the presence of a bromodomain-containing subunit, such as yeast Rsc1 or Rsc4, or the mammalian PB1/BAF180 protein, which confers unique targeting and regulatory properties. Unlike the canonical SWI/SNF complex, the RSC-type complex is generally recruited to RNA polymerase III promoters and is specifically recruited to RNA polymerase II promoters by transcriptional activators and repressors. This dual promoter targeting positions the RSC-type complex as a critical integrator of transcriptional programs and chromatin architecture. Beyond transcription, the RSC-type complex is also involved in non-homologous end joining (NHEJ), a major pathway for repairing DNA double-strand breaks. This functional duality underscores its importance in maintaining genomic stability and regulating gene expression. In mammalian cells, the orthologous PBAF complex (also known as the Polybromo- and BAF-containing complex) shares subunit composition and regulatory logic with the yeast RSC complex. Researchers study GO:0016586 to understand how chromatin remodeling influences RNA metabolism, cell proliferation, and DNA repair. Recent single-cell studies have revealed heterogeneity in epigenetic factor regulation, including RSC-type components, during proliferative SHH-medulloblastoma, highlighting its relevance to cancer biology. Thus, the RSC-type complex represents a convergence point for transcriptional control, genome stability, and disease mechanisms.

The RSC-type complex is a SWI/SNF-type chromatin remodeling complex that contains a bromodomain-containing protein, such as yeast Rsc1 or Rsc4 or mammalian PB1/BAF180. It is generally recruited to RNA polymerase III promoters and is specifically recruited to RNA polymerase II promoters by transcriptional activators and repressors; it is also involved in non-homologous end joining.

The RSC-type complex is essential for coordinating chromatin accessibility with transcriptional programs and DNA repair. Its ability to be recruited to both RNA polymerase III and RNA polymerase II promoters allows it to influence diverse gene expression networks, including those controlling cell proliferation and RNA metabolism. Dysregulation of RSC-type subunits has been linked to proliferative SHH-medulloblastoma, where single-cell heterogeneity of epigenetic factors alters RNA metabolism. Understanding this complex provides mechanistic insights into how chromatin remodelers contribute to cancer and other diseases, and offers potential targets for therapeutic intervention.

The following genes encode subunits or associated factors of the RSC-type complex across species, based on published literature.

The RSC-type complex is regulated at multiple levels, including subunit composition, post-translational modifications, and recruitment by transcriptional activators and repressors. Its bromodomain-containing subunits recognize acetylated histones, providing a feedback mechanism linked to the chromatin state. Additionally, single-cell studies have revealed heterogeneity in epigenetic factor regulation, including RSC-type components, during proliferative SHH-medulloblastoma, suggesting that its activity is dynamically modulated in disease contexts.

Single-cell heterogeneity of epigenetic factor regulation, including RSC-type complex components, has been shown to alter RNA metabolism during proliferative SHH-medulloblastoma. This suggests that dysregulation of the RSC-type complex contributes to the pathogenesis of this pediatric brain tumor.

Mutations in SWI/SNF family subunits, including those in the PBAF (RSC-type) complex, are recurrent in various cancers. The RSC-type complex's role in transcription and DNA repair makes it a potential tumor suppressor or oncogenic driver depending on context.

Alterations in RSC-type complex function can impact RNA metabolism, potentially contributing to diseases characterized by RNA processing defects. Further research is needed to establish direct links to specific RNA metabolism disorders.

RNA-seq and single-cell RNA-seq can reveal changes in RNA metabolism and gene expression upon RSC-type complex perturbation. These methods help identify transcriptional programs regulated by the complex.

ChIP-seq for RSC-type subunits or histone modifications can map genome-wide binding sites and chromatin states. This is crucial for understanding recruitment to RNA polymerase II and III promoters.

Affinity purification coupled with mass spectrometry can identify subunit composition and interacting partners of the RSC-type complex. This helps define assembly and regulatory networks.

Comet assays, gamma-H2AX staining, and NHEJ reporter systems can assess the role of the RSC-type complex in non-homologous end joining. These assays link chromatin remodeling to genome stability.

Researchers studying RSC-type complex-related genes often need to determine whether a candidate gene is causally involved in chromatin remodeling, transcription, or DNA repair. EDITGENE provides tailored CRISPR services to generate precisely engineered cell models for such investigations.

The RSC-type complex (GO:0016586) is a conserved SWI/SNF-family chromatin remodeler defined by bromodomain-containing subunits, with critical roles in RNA polymerase II and III transcription and non-homologous end joining. Its dysregulation is linked to proliferative SHH-medulloblastoma and altered RNA metabolism. Understanding its mechanisms through CRISPR-based models and multi-omics approaches will advance both basic chromatin biology and therapeutic development.